L01FG01 |
BioTech |
Bevacizumab - 100mg/4ml |
5554 |
221325/08 |
AVASTIN |
100mg/4ml |
1 x 4ml |
Injectable concentrated solution |
Infusion |
Omnipharma |
F. Hoffmann La Roche Manufacturing Site Kaiseraugst |
Switzerland |
24,533,456 L.L |
19.35 |
D |
F. Hoffmann La Roche Ltd |
Switzerland |
12/12/20 |
0 |
L01FG01 |
BioTech |
Bevacizumab - 100mg |
6109 |
167512/10 |
AVASTIN |
100mg |
1 x 4ml |
Injectable concentrated solution |
Infusion |
Omnipharma |
Roche Diagnostics GmbH |
Germany |
24,533,456 L.L |
19.35 |
D |
F. Hoffmann La Roche Ltd |
Switzerland |
12/12/20 |
0 |
L01FG01 |
BioTech |
Bevacizumab - 100mg/4ml |
10324 |
175219/1 |
STIVANT |
100mg/4ml |
1x4ml |
Injectable concentrate for solution |
Infusion |
Lebiran SARL |
Aryogen Pharmed |
Iran |
14,719,570 L.L |
19.35 |
D |
Aryogen Pharmed |
Iran |
12/12/20 |
0 |
L01FG01 |
BioTech |
Bevacizumab - 100mg/4ml |
11666 |
130823/1 |
BIVASTINA 100 |
100mg/4ml |
1x4ml |
Injectable concentrate for solution |
Infusion |
Benta Trading Co s.a.l. |
Manufactured by JSC Biocad, Russia for Benta SAL |
Lebanon |
18,490,076 L.L |
19.35 |
D |
|
|
12/12/20 |
0 |
L01FG01 |
BioTech |
Bevacizumab - 100mg/4ml |
10287 |
100120/1 |
ZIRABEV |
100mg/4ml |
1 |
Injectable solution |
Infusion |
Droguerie Fattal S.A.L. |
Pharmacia & Upjohn Company LLC |
USA |
17,173,671 L.L |
19.35 |
D |
Pfizer Inc |
USA |
12/12/20 |
0 |
L01FG01 |
BioTech |
Bevacizumab - 100mg/4ml |
10519 |
100520/1 |
MVASI |
100mg/4ml |
1x4ml |
Injectable concentrate for solution |
Infusion |
Mersaco |
Amgen Manufacturing Ltd |
USA |
17,173,671 L.L |
19.35 |
D |
Amgen Technology (Ireland) Unlimited Company |
Ireland |
12/12/20 |
0 |
L01FG01 |
BioTech |
Bevacizumab - 100mg/4ml |
11597 |
107023/1 |
BEVACIREL |
100mg/4ml |
1x4ml |
Injectable solution |
Infusion |
Levant Pulse SARL |
Reliance Life Sciences pvt Ltd |
India |
14,719,570 L.L |
19.35 |
D |
|
India |
12/12/20 |
0 |
L01FG01 |
BioTech |
Bevacizumab - 100mg/4ml |
11597/388 |
107023/1 |
BEVACIREL |
100mg/4ml |
1x4ml |
Injectable solution |
Infusion |
Levant Pulse SARL |
Reliance Life Sciences pvt Ltd |
India |
L.L |
19.35 |
D |
|
India |
05/02/20 |
|